Blood Pump
Wearable external blood pump
The Amplifi Vein Dilation System is designed to stimulate arm vein enlargement in hemodialysis patients using rapid, non-pulsatile blood flow. Amplifi aims to increase eligibility for arteriovenous fistula (AVF) surgery, reduce AVF maturation failure, and prolong AVF patency*. The system under development is a wearable, external blood pump with inflow and outflow catheters (with ports which can be used to provide access for hemodialysis during the treatment period), and a controller with a rechargeable battery. Amplifi is used for 7 to 10 days and is removed during AVF creation.
The National Kidney Foundation recommends AVF as the preferred form of vascular access for most hemodialysis patients.17 However, many patients have small veins, making then ineligible for AVF or at high risk of AVF maturation failure.18,19 Artio’s vein dilation device has the potential to increase the number of patients who are eligible for an AVF and decrease the risk of maturation failure.
Larger AVF vein diameters and increased AVF blood flow are correlated with successful AVF use.18-20 Using the Amplifi Vein Dilation System to increase the diameter of arm veins before AVF surgery has the potential to provide sustained and reliable vascular access for hemodialysis patients.
A reliable access site for hemodialysis provides confidence to patients and physicians that lifesaving hemodialysis treatment will be available when needed.
Hover over the underlined words to see device components highlighted.
Blood Pump
Wearable external blood pump
Inflow Catheter
Flexible catheter placed in the central venous system to connect to the patient’s bloodstream
Outflow Catheter
Flexible catheter inserted into the peripheral arm vein intended to be enlarged
Controller
Controller with rechargeable battery to adjust pump speed to provide additional blood flow as the vein dilates throughout the procedure
Access Ports
Two access ports, one on each catheter, to enable vascular access
Using the Amplifi Vein Dilation System prior to access creation could enable more patients to get an AVF and increase AVF use.
AVFs created with veins pre-treated with the Amplifi Vein Dilation System may require fewer interventions to reach maturity.
For more information about Artio’s peripheral embolization solutions, contact us.
* Primary patency
The Amplifi Vein Dilation System is currently at the R&D stage and not available for sale. It is under clinical investigation in South America only.